Vitamin D receptor in endometrial carcinoma and the differentiation-inducing effect of 1,25-dihydroxyvitamin D3 on endometrial carcinoma cell lines

Journal of Obstetrics and Gynaecology Research

Volumn 22, Issue 6, 1996, Pages 529-539

  Yabushita, Hiromitsu ^a   Hirata, Masato ^a   Noguchi, Masayoshi ^a   Nakanishi, Masami ^a  

^a AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

1,25 dihydroxyvitamin D3; Differentiation induction,; Endometrial carcinoma; Vitamin D receptor

Indexed keywords

CALCITRIOL; COLLAGEN GEL; CYTOKERATIN; VITAMIN D RECEPTOR;

ADENOCARCINOMA; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CELL MATURATION; CONTROLLED STUDY; CULTURE MEDIUM; ENDOMETRIUM CARCINOMA; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; TUMOR CELL LINE;

EID: 0030453742     PISSN: 13418076     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1447-0756.1996.tb01068.x     Document Type: Article

References (33)

1. Christensen C, Deppe G, Saunders D, Malviya V. The use of a human endometrial carcinoma cell line (RL95-2) for in vitro testing of chemo-therapeutic agents. Gynecol Oncol 1987; 28: 25-33
2. Seski J, Edwards C, Herson J, Rutledge F. Cisplatin chemotherapy for disseminated endometrial cancer. Obstet Gynecol 1982; 59: 225-228
3. Thigpen J, Buchsbaum H, Mangan C, Blessing J. Phase II trial of adriamycin in the treatment of advanced or recurrent endometrial adenocarcinoma: A Gynecologic Oncology Group Study. Cancer Treat Rep 1979; 63: 21-27
4. Deppe GE, ed. Chemotherapy of gynecologic cancer, New York: Wiley-Liss, 1990
5. Thigpen T, Blessing J, DiSaia P. Treatment of advanced or recurrent endometrial carcinoma with medroxyprogesterone (MPA): A Gynecologic Oncology Group Study. Gynecol Oncol 1985; 20: 250-254
6. 3. Endocr Rev 1985; 6: 491-511
7. Green S, Chambon P. A superfamily of potentially oncogenic hormone receptors. Nature (London) 1986; 324: 615-617
8. Eisman JA, Martin TJ, MacIntyre I, Moseley JM. 1,25-Dihydroxyvitamin-D receptor in breast cancer cells. Lancet 1979; 2: 1335-1336
9. 3 and malignant melanoma: The presence of receptors and inhibition of cell growth in culture. Endocrinology 1981; 108: 1083-1086
10. Freake HC, MacIntyre I. Specific binding of 1,25-dihydroxycholecalciferol in human medullary thyroid carcinoma. Biochem J 1982; 206: 181-184
11. 3. Proc Natl Acad Sci USA 1981; 78: 4990-4994
12. 3 induces maturation of the human monocyte cell line U937, and in association with a factor from human T lymphocytes, augments production of the monokine, mononuclear cell factor. J Clin Invest 1984; 73: 731-739
13. Saulenas AM, Cohen SM, Key LL, Winter C, Albert DM. Vitamin D and retinoblastoma: The presence of receptors and inhibition of growth in vitro. Arch Ophthamol 1988; 106: 533-535
14. Christopherson WA, Porter JC, MacDonald PC, Casey ML. Responsiveness of human carcinoma cells of gynecologic origin to 1,25-dihydroxycholecalciferol. Am J Obstet Gynecol 1986; 155: 1293-1296
15. Yabushita H, Masuda T, Sawaguchi K, Noguchi M, Nakanishi M. Establishment and characterization of a new human cell line (AMEC-1) derived from the endometrial cancer. Tokai J Obstet Gynaec 1990; 27: 25-34
16. Way D, Grosso D, Davis J, Surwit E, Christian C. Characterization of a new human endometrial carcinoma (RL-95-2) established in tissue culture. In Vitro 1983; 19: 147-151
17. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 277: 680-685
18. Towbin H, Staehelin T, Gordon J. Electro-phoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad USA 1979; 76: 4350-4354
19. Dexter DL, Hagen JC. Maturation-induction of tumor cells using a human colon carcinoma model. Cancer (Phila) 1980; 45: 1178-1184
20. Graham KA, Buick RN. Sodium butyrate induces differentiation in breast cancer cell lines expressing the estrogen receptor. J Cell Physiol 1988; 136: 63-71
21. Azuma M, Hayashi Y, Yosida H, Yanagawa T, Yura Y, Ueno A, Sato M. Emergence of differentiated subclones from a human salivary adenocarcinoma cell line in culture after treatment with sodium butyrate. Cancer Res 1986; 46: 770-777
22. Brooks SE, Timmerman J, Lau CC, Tsao SW, Knapp RC, Sheets EE. Effect of differentiation agents on expression of CA125, alkaline phosphatase, and cytokeratins in human ovarian adenocarcinoma cells (OVCA 433). Gynecol Oncol 1991; 42: 265-272
23. Yabushita H, Sartorelli AC. Effects of sodium butyrate, dimethylsulfoxide and dibutyryl cAMP on the poorly differentiated ovarian adenocarcinoma cell line AMOC-2. Oncol Res 1993; 4/5: 173-182
24. 3 in gynecologic neoplasms. Gynecol Oncol 1992; 44: 2131-2136
25. Sun TT, Eichner R, Nelson WG, Tseng SC, Weiss RA, Jarvinen M, Woodcock-Mitchell J. Keratin classes: Molecular markers for different types of epithelial differentiation. J Invest Dermatol 1983; 81: 109s-115s
26. Fuchs E. Keratins as biochemical markers of epithelial differentiation. Trends Genet 1988; 4: 277-281
27. Cooper D, Schermer A, Sun TT. Biology of disease classification of human epithelia and their neoplasms using monoclonal antibodies to keratins: Strategies, applications and limitations. Lab Invest 1985; 52: 243-256
28. Yabushita H, Narumiya H, Furuya H, Tsukada H, Sawaguchi K, Noguchi M, Nakanishi M. Immunohistochemical study vimentin, cytokeratin, and CA125 in Stage I endometrial adenocarcinoma. J Aichi Med Univ Assoc 1994; 22: 473-481
29. 3 prolong survival time of mice inoculated with myeloid leukemia cells. Proc Natl Acad Sci USA 1983; 80: 201-204
30. Albert DM, Saulenas AM, Cohen SM. Verhoeff's query: Is vitamin D effective against retinoblastoma? Arch Ophthalmol 1988; 106: 536-540
31. 3 one of the endogenous substances regulating calcium metabolism. J Intl Med Res 1988; 16: 125-133
32. 3: Preferential activity in inducing differentiation of HL-60 human leukemia cells in vitro. Proc Natl Acad Sci USA 1987; 84: 2610-2614
33. Binderup L, Bramm E. Effects of a novel vitamin D analogue MC903 on cell proliferation and differentiation. Biochem Pharmacol 1988; 37: 889-895